Diclofenac and Abraxane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diclofenac (diclofenac) and Abraxane (paclitaxel). Common drug interactions include diarrhoea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Diclofenac and Abraxane. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Diclofenac?

Diclofenac has active ingredients of diclofenac. eHealthMe is studying from 41,319 Diclofenac users. Check the latest studies of Diclofenac.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.



On Jul, 09, 2026

44 people who take Diclofenac and Abraxane together, and have interactions are studied.

Diclofenac and Abraxane drug interactions.

What are the common drug interactions of Diclofenac and Abraxane, by gender? *:

female:

  1. Diarrhoea
  2. Urinary tract infection
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Cholecystitis (infection of gallbladder)
  6. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
  7. Pyrexia (fever)
  8. Abdominal pain upper
  9. Constipation
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Chest pain
  4. Sputum increased
  5. Acute respiratory failure
  6. Constipation
  7. Hyperglycaemia (high blood sugar)
  8. Leukopenia (less number of white blood cells in blood)
  9. Meningitis cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  10. Type 2 diabetes mellitus

What are the common drug interactions of Diclofenac and Abraxane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Haematoma infection (infection with collection of blood outside the blood vessels)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)

30-39:

  1. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
  2. Bullous impetigo (contagious bacterial skin infection in newborn)

40-49:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Dyspnoea (difficult or laboured respiration)
  3. Muscular weakness (muscle weakness)
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Asthenia (weakness)
  6. Death
  7. Diarrhoea
  8. Gait disturbance
  9. Hospitalisation

50-59:

  1. Pyrexia (fever)
  2. Abdominal pain
  3. Abdominal pain upper
  4. Constipation
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  8. Rash
  9. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  10. Diarrhoea

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Urinary tract infection
  3. Sputum increased
  4. Acute respiratory failure
  5. Constipation
  6. Hyperglycaemia (high blood sugar)
  7. Leukopenia (less number of white blood cells in blood)
  8. Meningitis cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  9. Type 2 diabetes mellitus
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Constipation: 23 people, 52.27%
  2. Abdominal Pain: 20 people, 45.45%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 40.91%
  4. Pancreatic Carcinoma (pancreatic cancer): 16 people, 36.36%
  5. Diabetes: 15 people, 34.09%
  6. Insomnia (sleeplessness): 15 people, 34.09%
  7. Indigestion: 13 people, 29.55%
  8. Dyspnea (difficult or laboured breathing): 12 people, 27.27%
  9. Nausea (feeling of having an urge to vomit): 9 people, 20.45%
  10. Nausea And Vomiting: 8 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Diclofenac and Abraxane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diclofenac and Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diclofenac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diclofenac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abraxane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac and paclitaxel (the active ingredients of Diclofenac and Abraxane, respectively), and Diclofenac and Abraxane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: